Jussi Halleen, PhD, Adjunct Professor Chief Executive Officer (CEO), Chairman
Jussi was the founder and CEO for 21 years of a preclinical CRO specialised in oncology and bone diseases. He has developed and patented globally a bone biomarker diagnostic method that received President of Finland’s InnoSuomi award in 2000 and became a commercial success story.
Tiina Kähkönen, PhD Chief Scientific Officer (CSO)
Tiina was a Research Director and CSO in a preclinical CRO. She has led many projects for pharma clients and several EU-funded R&D projects for developing preclinical bone metastasis models. She is a globally acknowledged scientific expert with strong laboratory and technology expertise in bone metastasis models.
Lorenza Castellon, PhD Non-executive director
Lorenza has over 20 years of experience working with a wide range of private and listed innovative pharma, biotech and life sciences organisations across different therapeutic areas in the UK and internationally. Her professional experience covers different roles including investment banking consulting, health & biotech equity research analyst, licensing and business development.